Navigation Links
Lilly Provides Update on 2011 Financial Guidance Due to Xigris Withdrawal
Date:10/25/2011

INDIANAPOLIS, Oct. 25, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has updated its full-year 2011 financial guidance as a result of the announced withdrawal of the company's Xigris® product.

Lilly expects to incur a charge in the fourth quarter of 2011 for asset impairments and contractual commitments related to Xigris. The exact amount of the charge has not yet been determined, but is estimated to be in the range of $75.0 million to $95.0 million (pre-tax), or approximately $.05 per share (after tax).

Lilly's full-year 2011 earnings per share guidance on a non-GAAP basis remains unchanged at $4.30 to $4.35. On a reported basis, including the Xigris asset impairment charge, Lilly now expects its full-year 2011 earnings per share to be in the range of $3.84 to $3.89. See the reconciliation below for further detail.

2011 Earnings Per Share Expectations:2011 Expectations2010

Results% GrowthEarnings per share (reported)$3.84 to $3.89$4.58(15)% to (16)%In-process research and development charges associated with
Boehringer Ingelheim collaboration (2011) and Acrux
licensing agreement (2010).23.03Asset impairments and restructuring charges:

Year-to-date charges

Estimated Xigris charge.18

.05.13

-Earnings per share (non-GAAP)$4.30 to $4.35$4.74(8)% to (9)%About Eli Lilly and CompanyLilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs.  Additional information about Lilly is available at www.lilly.com.  C-LLY

This
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Research explores data ... research also   to   be presented ... ), the global specialty biopharmaceutical company, announces that it ... the American Psychiatric Association (APA) 166th Annual Meeting in ... data being presented represent Shire,s ongoing commitment to the ...
(Date:5/17/2013)... MIAMI LAKES, Fla. , May 17, 2013 ... products and delivery technology company that is developing new, patent-pending ... and minerals, announced today that it will hold a business ... on Wednesday, May 22 nd , 2013 at 4:30 PM ... Brian Tuffin will host the call and will ...
(Date:5/17/2013)... , May 17, 2013 ... developer of oral drug delivery systems, announced today that ... cleared the Company,s Investigational New Drug application(IND) for ORMD-0801, ... pleased to have the FDA clearance to proceed," stated ... "The upcoming trial is a major milestone for Oramed ...
Breaking Medicine Technology:Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3
... Aug. 19 Perrigo Company (Nasdaq: PRGO;TASE) announced its ... for its Abbreviated New Drug Application (ANDA) for clobetasol ... owner. On August 17, 2010, Galderma filed ... Court for the Northern District of Texas to prevent ...
... 19 Reportlinker.com announces that a new market ... Strategic Analysis of End-user Preferences in ... http://www.reportlinker.com/p0258289/Strategic-Analysis-of-End-user-Preferences-in-the-US-Stem-Cell-Research-Tools-Markets.html The ... brand perceptions of tools and technologies currently at ...
Cached Medicine Technology:Perrigo Confirms Filing for Clobetasol Shampoo and Announcement of Patent Infringement Lawsuit by Galderma 2Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets 2Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets 3
(Date:5/19/2013)... May 19, 2013 Passages Malibu, the ... center, has announced this week the launch of a ... brands’ social media channels. “We are always looking ... community and to get feedback regarding sobriety, what’s working ... and co-founder of the Passages Addiction Treatment Centers ...
(Date:5/19/2013)... The AMTC team will be screening local ... Convention & Trade Center on June 1st. Professionals and amateurs, ... are free of charge. , Actors, Models and Talent for ... successful artists and grads like Caitlin Kinney - SYTYCD, ... Chris Young - on his Liquid Neon 2013 Tour, Taylor ...
(Date:5/19/2013)... 2013 The legal team at Pulaski ... a concerted effort to connect women and families coping ... drugs Yaz, Yasmin & Ocella with the legal representation ... on the notorious birth control drugs as well as ... , Yaz, Yasmin & Ocella were very popular birth ...
(Date:5/18/2013)... In “Cooking with Spirits for the Spirit: A ... Hall Svisdahl’s new cookbook, readers are transported into the world ... the pickiest eater drool. “I dedicate this book to the ... , Found within the 364 pages of “Cooking with Spirits ... from fast and simple to gourmet. Each recipe greets the ...
(Date:5/18/2013)... 2013) Each year, the American Gastroenterological Association ... and achievements in gastroenterology through its esteemed recognition ... and talented individuals who work tirelessly to advance ... are pleased to announce the 2013 recognition award ... for their tremendous contributions to our field," said ...
Breaking Medicine News(10 mins):Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 3Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 5
... , ... The National Institutes of Health (NIH) has awarded a “Grand ... Lencz, PhD, at The Feinstein Institute for Medical Research and Ariel Darvasi, ... the genetic basis of schizophrenia. More than two million dollars was awarded ...
... necessary, safe or effective , FRIDAY, Oct. 9 (HealthDay News) ... kids vaccinated against seasonal influenza or H1N1 swine flu this ... is fighting the flu on her own terms -- ... hands frequently, get plenty of sleep and take their "gummies," ...
... Strong Corporate Values, Employee Engagement and Contributions ... Place to Work, , OTTAWA, Oct. 9 /PRNewswire-FirstCall/ - ... radiopharmaceuticals, has been selected as one of Canada,s Top ... largest publisher of employment-related periodicals and online directories. , ...
... Oct. 9 The outcome of the current healthcare ... need to get healthier. From childhood obesity to alarming ... U.S. have been confronted with the consequences of lives ... the healthcare crisis, it,s that over-emphasizing one part of ...
... Genomma Lab Internacional,S.A.B. de C.V. ("Genomma") (BMV: LAB) announced ... Televisa, S.A.B.,(NYSE: TV ; BMV: TLEVISA CPO), which was ... cosmetics and over-the-counter pharmaceuticals,in the United States and Puerto Rico. ... operations during the first quarter of 2010. , ...
... SINGAPORE, Oct. 9 The global diagnostics industry has ... to Frost & Sullivan, the diagnostics and monitoring sectors ... Nitin Naik, Vice President of Frost & Sullivan,s Asia ... in Asia Pacific are projected to provide more growth ...
Cached Medicine News:Health News:Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia 2Health News:'No Flu Shots for My Kids' 2Health News:'No Flu Shots for My Kids' 3Health News:'No Flu Shots for My Kids' 4Health News:MDS Nordion Selected One of Canada's Top 100 Employers for 2010 2Health News:The Holistic Health Show Offers Relief for Healthcare Crisis 2Health News:Singapore Witnesses Healthy Growth in Diagnostics Industry 2Health News:Singapore Witnesses Healthy Growth in Diagnostics Industry 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: